Clinical Safety

Are Heart Meds Enough Without a Healthy Diet?
Research & Development Are Heart Meds Enough Without a Healthy Diet?

The quiet confidence that comes with taking a daily pill to manage cholesterol or blood pressure often masks a dangerous misconception that its protective shield is impenetrable, regardless of what one eats. This belief, however, is being challenged by rigorous scientific inquiry, forcing a

New Obesity Pill Shows Major Weight Loss in Mid-Stage Trial
Research & Development New Obesity Pill Shows Major Weight Loss in Mid-Stage Trial

An experimental oral medication for obesity has delivered substantial weight loss in a mid-stage trial, heralding the arrival of a formidable new challenger in a market dominated by pharmaceutical titans. Co-developed by Hengrui Pharma and Kailera Therapeutics, the pill, known as ribupatide,

Can AI Make Food Safety Testing Flawless?
Tech & Innovation Can AI Make Food Safety Testing Flawless?

As a biopharma expert deeply involved in technological innovation, Ivan Kairatov has been at the forefront of applying advanced science to solve critical industry challenges. Today, he joins us to discuss a groundbreaking development in food safety: an artificial intelligence system that

Is Conversational AI the Next Step for Clinical Trials?
Research & Development Is Conversational AI the Next Step for Clinical Trials?

The integration of advertising into conversational AI platforms like ChatGPT is poised to subtly yet profoundly reshape how patients discover and consider clinical research, representing not a radical upheaval but a significant evolutionary step in digital communication. This development marks a

Are Enzymes Programmable Molecular Machines?
Research & Development Are Enzymes Programmable Molecular Machines?

The long-held view of enzymes as nature's exquisitely specific but single-minded catalysts is undergoing a profound transformation, giving way to a new paradigm that reimagines them as versatile, programmable molecular machines. This significant shift, fueled by remarkable discoveries in natural

Targeting Pro-Tumor Neutrophils – Review
Research & Development Targeting Pro-Tumor Neutrophils – Review

The intricate landscape of the tumor microenvironment is increasingly recognized not as a simple collection of malignant cells, but as a complex ecosystem where cancer’s fate is dictated by a dynamic interplay with the body's own immune system. The targeting of specific immune cell subsets

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later